Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial

被引:6
|
作者
Sabzehei, Mohammad Kazem [1 ]
Basiri, Behnaz [1 ]
Shokouhi, Maryam [1 ]
Ghahremani, Sajad [1 ]
Moradi, Ali [2 ]
机构
[1] Hamadan Univ Med Sci, Dept Pediat, Hamadan, Hamadan, Iran
[2] Hamadan Univ Med Sci, Hlth Deputy, Hamadan, Hamadan, Iran
关键词
Respiratory distress syndrome; Preterm infant; Insure; Minimally invasive surfactant therapy; THIN CATHETER; RISK-FACTORS; NEWBORNS; TUBE;
D O I
10.3345/cep.2021.00297
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Respiratory distress syndrome (RDS) is a common cause of hospitalization and death in preterm infants who require surfactant treatment and respiratory support. Purpose: This study aimed to compare the clinical outcomes of minimally invasive surfactant therapy (MIST) and the INtubation, SURfactant administration, and Extubation (INSURE) technique in preterm infants with RDS. Methods: In this clinical trial, 112 preterm infants born at 28-36 weeks of gestation and diagnosed with RDS randomly received 200-mg/kg surfactant by MIST or the INSURE method. In the MIST group, surfactant was administered using a thin catheter (5F feeding tube); in the INSURE group, surfactant was administered after intubation using a feeding tube and the tracheal tube was removed after positive pressure ventilation was started. Nasal continuous positive airway pressure was applied in both groups for respiratory support and the postprocedure clinical outcomes were compared. Results: The mean hospitalization time was shorter for infants in the MIST group than for those in the INSURE group (9.19 +/- 1.72 days vs. 10.21 +/- 2.15 days, P=0.006). Patent ductus arteriosus was less frequent in the MIST group (14.3% vs. 30.4%, P=0.041). Desaturation during surfactant administration occurred less commonly in the MIST group (19.6% vs. 39.3%, P=0.023). There were no significant intergroup differences in other early or late complications. Conclusion: These results suggest that surfactant administration using MIST could be a good replacement for INSURE in preterm infants with RDS since its use reduced the hospitalization time and the number of side effects.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 50 条
  • [1] Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial
    Pareek, Prince
    Deshpande, Sujata
    Suryawanshi, Pradeep
    Sah, Love Kumar
    Chetan, Chinmay
    Maheshwari, Rajesh
    More, Kiran
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 2021, 67 (04)
  • [2] Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome
    Wang, Xing-An
    Chen, Lih-Ju
    Chen, Shan-Ming
    Su, Pen-Hua
    Chen, Jia-Yuh
    [J]. PEDIATRICS AND NEONATOLOGY, 2020, 61 (02): : 210 - 215
  • [3] Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome
    Halim, Alia
    Shirazi, Haider
    Riaz, Sadia
    Gul, Syeda Shireen
    Ali, Wahid
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (03): : 226 - 230
  • [4] Surfactant administration without intubation in preterm infants with respiratory distress syndrome - our experiences
    Krajewski, Pawel
    Chudzik, Anita
    Strzalko-Gloskowska, Barbara
    Gorska, Monika
    Kmiecik, Magdalena
    Wieckowska, Katarzyna
    Mesjasz, Anna
    Sieroszewski, Piotr
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (10): : 1161 - 1164
  • [5] Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies
    Aguar, Marta
    Cernada, Maria
    Brugada, Maria
    Gimeno, Ana
    Gutierrez, Antonio
    Vento, Maximo
    [J]. ACTA PAEDIATRICA, 2014, 103 (06) : E229 - E233
  • [6] Less invasive surfactant administration by umbilical catheter is safe and effective for treating respiratory distress syndrome in preterm infants
    Truong, Thao Thuy
    Tran, Hoang Thi
    Skinner, Alyson
    Narchi, Hassib
    [J]. ACTA PAEDIATRICA, 2023, 112 (04) : 706 - 707
  • [8] Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis
    Aldana-Aguirre, Jose C.
    Pinto, Merlin
    Featherstone, Robin M.
    Kumar, Manoj
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2017, 102 (01): : F17 - F23
  • [9] Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome The OPTIMIST-A Randomized Clinical Trial
    Dargaville, Peter A.
    Kamlin, C. Omar F.
    Orsini, Francesca
    Wang, Xiaofang
    De Paoli, Antonio G.
    Kutman, H. Gozde Kanmaz
    Cetinkaya, Merih
    Kornhauser-Cerar, Lilijana
    Derrick, Matthew
    Ozkan, Hilal
    Hulzebos, Christian, V
    Schmolzer, Georg M.
    Aiyappan, Ajit
    Lemyre, Brigitte
    Kuo, Sheree
    Rajadurai, Victor S.
    O'Shea, Joyce
    Biniwale, Manoj
    Ramanathan, Rangasamy
    Kushnir, Alla
    Bader, David
    Thomas, Mark R.
    Chakraborty, Mallinath
    Buksh, Mariam J.
    Bhatia, Risha
    Sullivan, Carol L.
    Shinwell, Eric S.
    Dyson, Amanda
    Barker, David P.
    Kugelman, Amir
    Donovan, Tim J.
    Tauscher, Markus K.
    Murthy, Vadivelam
    Ali, Sanoj K. M.
    Yossuck, Pete
    Clark, Howard W.
    Soll, Roger F.
    Carlin, John B.
    Davis, Peter G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2478 - 2487
  • [10] Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
    Jardine, Luke
    Lui, Kei
    Liley, Helen G.
    Schindler, Timothy
    Fink, James
    Asselin, Jeanette
    Durand, David
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2022, 107 (01): : 51 - 55